The prohormone convertases (PCs) PC1 and PC2 are key enzymes capable of pro
cessing a variety of prohormones to their bioactive forms. In this study, w
e demonstrated that 6-n-propyl-2-thiouracil (PTU)-induced hypothyroidism st
imulated, whereas triido-L-thyronine (T-3)-induced hyperthyroidism suppress
ed, PC1 mRNA levels in the rat anterior pituitary. Using 5' deletions of th
e human PC1 (hPC1) promoter transiently transfected into GH3 (a somatotroph
cell line) cells, we found that T-3 negatively regulated hPC1 promoter act
ivity and that this regulation required the region from -82 to +19 bp relat
ive to the transcription start site. Electrophoretic mobility shift assays
(EMSAs) using purified thyroid hormone receptor-alpha1 (TR alpha1) and reti
noid X receptor-beta (RXR beta) proteins and GH3 nuclear extracts demonstra
ted that the region from -10 to +19 bp of the hPC1 promoter bound TR alpha1
as both a monomer and a homodimer and bound TR alpha1/RXR beta as a hetero
dimer and multimer. EMSAs with oligonucleotides containing point mutations
of the putative negative thyroid response elements (TREs) exhibited diminis
hed homodimer and loss of multimer binding. We conclude that there are mult
iple novel TRE-like sequences in the hPC1 promoter located from -10 to +19
bp.